TITLE

Adult immunization with 13-valent pneumococcal vaccine in Campania region, South Italy

AUTHOR(S)
Liguori, Giorgio; Parlato, Antonino; Sanduzzi Zamparelli, Alessandro; Belfiore, Patrizia; Gallé, Francesca; Di Onofrio, Valeria; Riganti, Carla; Zamparelli, Bruno
PUB. DATE
February 2014
SOURCE
Human Vaccines & Immunotherapeutics;Feb2014, Vol. 10 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
94752448

 

Related Articles

  • ACIP updates recommendations for prevention of invasive pneumococcal vaccine among adults.  // Infectious Diseases in Children;Oct2010, Vol. 23 Issue 10, p47 

    The article presents recommendations updated by the U.S. Advisory Committee on Immunization Practices for the use of the 23-valent pneumococcal polysaccharide vaccine for the prevention of invasive pneumococcal disease in adults.

  • Pneumococcal Conjugate Vaccine for Adults: A New Paradigm. Paradiso, Peter R. // Clinical Infectious Diseases;Jul2012, Vol. 55 Issue 2, p259 

    A 13-valent pneumococcal conjugate vaccine (PCV13), recently approved for use in adults, induced an overall superior functional antibody response compared with the 23-valent pneumococcal polysaccharide vaccine. PCV13 elicits immunological memory and provides a new approach to preventing...

  • ACIP Expands PCV13 Immunization Recommendations for Some Adults.  // American Family Physician;8/1/2012, Vol. 86 Issue 3, p226 

    The article reports on the recommendation of the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC) regarding the use of the 13-valent pneumococcal conjugate vaccine (PCV13) in adults.

  • Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older -- United States, 2015. Kim, David K.; Bridges, Carolyn B.; Harriman, Kathleen H. // MMWR: Morbidity & Mortality Weekly Report;2/6/2015, Vol. 64 Issue 4, p91 

    The article focuses in the immunization schedule for adults in the U.S. in 2015 which was approved by the Advisory Committee on Immunization Practices (ACIP) in October 2014. Topics discussed include the recommendation for routine administration of the 13-valent pneumococcal conjugate vaccine...

  • PCV13 more cost-effective than PPSV23 among adults. Smith, Kenneth J. // Infectious Disease News;Mar2012, Vol. 25 Issue 3, p38 

    The article reports on a study which found that 13-valent pneumococcal conjugate vaccine was more cost-effective compared with a 23-valent pneumococcal polysaccharide vaccine among adults in the U.S.

  • Latest PPSV23 guideline update from ACIP.  // PharmacoEconomics & Outcomes News;10/16/2010, Issue 614, p8 

    The article cites some of the new guidelines issued by the Advisory Committee on Immunization Practices for the use of 23-valent pneumococcal polysaccharide vaccine for the prevention of invasive pneumococcal disease.

  • Pneumococcal vaccines for older adults: Getting the timing right. Campos-Outcalt, Doug // Journal of Family Practice;Dec2014, Vol. 63 Issue 12, p730 

    The article focuses on the use of pneumococcal vaccines for older patients with pneumococcal disease. Topics include the addition of 13-valent pneumococcal conjugate vaccine (PCV13) to the routine immunization schedule for adult patients based on the recommendation of the U.S. Advisory Committee...

  • Erratum.  // Drugs;2012, Vol. 72 Issue 16, p2176 

    A correction to the article "Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed): In Older Adults" that was published in the June 2012 issue is presented.

  • Pneumococcal vaccine effective in older adults.  // Infectious Disease News;Jun2011, Vol. 24 Issue 6, p28 

    The article reports on a study which revealed the effectiveness of the 13-valent pneumococcal conjugate vaccine in older adults.

  • Reply to Trück et al. Musher, Daniel M. // Clinical Infectious Diseases;Dec2012, Vol. 55 Issue 11, p1579 

    A letter to the editor is presented in response to the article on the routine application of 13-valent protein-conjugate pneumococcal vaccine in adults.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics